(Q44444385)

3 December 2017

title

Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis (English)

1 reference

3 December 2017

Gevaert P

1

1 reference

3 December 2017

Bachert C

2

1 reference

3 December 2017

Holtappels G

3

1 reference

3 December 2017

Novo CP

4

1 reference

3 December 2017

Van der Heyden J

5

1 reference

3 December 2017

Fransen L

6

1 reference

3 December 2017

Depraetere S

7

1 reference

3 December 2017

Walter H

8

1 reference

3 December 2017

van Cauwenberge P

9

1 reference

3 December 2017

Tavernier J

10

1 reference

3 December 2017

publication date

1 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

58

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

371-379

1 reference

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

Total and specific IgE in nasal polyps is related to local eosinophilic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

Biochemical and functional characterization of soluble form of IL-5 receptor alpha (sIL-5R alpha). Development of ELISA system for detection of sIL-5R alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

Molecular cloning and expression of the human interleukin 5 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

IL-5 synthesis is upregulated in human nasal polyp tissue1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

7 January 2021

GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

7 January 2021

Nasal polyposis: from cytokines to growth.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

7 January 2021

Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

7 January 2021

Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

7 January 2021

Autocrine interaction between IL-5 and IL-1beta mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

7 January 2021

Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

7 January 2021

Interleukin-5: a novel target for asthma therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00110.X

7 January 2021

10.1034/J.1398-9995.2003.00110.X

Identifiers

DOI

1 reference

3 December 2017

1 reference